Table 1.
Characteristics of the 177 primary lung cancer patients and the tumors
Lung cancer patients (n = 177) | |
---|---|
Mean age (range) |
77.3 ± 7.0 (55–92) |
Gender (male: female) |
132:45 |
Pathology of the tumor (Ad: SCLC: SCC:spindle cell carcinoma*: unspecified**:unknown***) |
89:7:47:1:9:24 |
Tumor diameter (average ± standard deviation) |
8–55 mm(30.0 ± 9.1) |
Tumor-chest wall distance (median) |
0–53 mm(6) |
**Range of follow-up period (median) |
6–95 months (23) |
Method of radiotherapy (48 Gy/4fr:60Gr/10fr:70Gr/10fr) |
95:45:37 |
BED10 of the isocenter (median) | 96–119 Gy (105.6) |
Abbreviations: Ad = adenocarcinoma, SCLC = small cell lung cancer, SCC = squamous cell carcinoma, BED = biologically effective dose.
*Suspicious of pleomorphic carcinoma, but a definitive diagnosis was not made because of needle biopsy.
**“unspecified” indicates pathologically definitive non-small cell lung carcinoma, but unspecified for the subtype.
***“unknown” indicates clinically highly suspicious for lung cancer but no pathology obtained.